Atlas Trials

First Line Osimertinib in the Real World: an Inter-regional Prospective Study

Clinical trial NCT04965701 · COMPLETED

Trial details

NCT number
NCT04965701
Sponsor
Istituto Oncologico Veneto IRCCS
Status
COMPLETED
Study type
OBSERVATIONAL
EGF-R Positive Non-Small Cell Lung Cancer
Start date
2018-06-01
Primary completion
2022-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.